Primaa Overview
- Year Founded
-
2018
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$8.16M
- Investors
-
14
Primaa General Information
Description
Developer of a medical diagnostic software designed for automated and accurate histological diagnoses. The company's software is an artificial intelligence-based tool that facilitates cancer detection by digitizing slides and collecting images in a database, enabling clients to digitally identify tissue damage and perform an increasing number of diagnoses while maintaining reliability.
Contact Information
Website
www.primaalab.comCorporate Office
- 10 rue Bachaumont
- 75002 Paris
- France
Corporate Office
- 10 rue Bachaumont
- 75002 Paris
- France
Primaa Timeline
Primaa Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 29-Oct-2025 | $8.16M | Completed | Generating Revenue | ||
| 5. Later Stage VC | 18-Nov-2024 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 28-Jul-2022 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 20-Apr-2020 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 11-Oct-2019 | $2.2M | $2.2M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | 01-Oct-2019 | Completed | Generating Revenue |
Primaa Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary A | ||||||||
| Ordinary A | ||||||||
| Shares B | 129,516 | $19.35 | $19.35 | 1x | $19.35 | 13.6% | ||
| Ordinary A | 132,776 | $10.49 | $10.49 | 1x | $10.49 | 13.95% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Primaa Comparisons
Industry
Financing
Details
Primaa Competitors (3)
One of Primaa’s 3 competitors is AI Medical Service, a Venture Capital-Backed company based in Tokyo, Japan.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| AI Medical Service | Venture Capital-Backed | Tokyo, Japan | ||||
| Optellum | Venture Capital-Backed | Oxford, United Kingdom | ||||
| ScreenPoint Medical | Venture Capital-Backed | Nijmegen, Netherlands |
Primaa Signals
Primaa Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Elaia Partners | Venture Capital | Minority | ||
| Super Capital | Venture Capital | Minority | ||
| SWEN Capital Partners | Mezzanine | Minority | ||
| Cenitz | Venture Capital | Minority | ||
| Clery | Impact Investing | Minority |
Primaa FAQs
-
When was Primaa founded?
Primaa was founded in 2018.
-
Where is Primaa headquartered?
Primaa is headquartered in Paris, France.
-
What is the size of Primaa?
Primaa has 25 total employees.
-
What industry is Primaa in?
Primaa’s primary industry is Decision/Risk Analysis.
-
Is Primaa a private or public company?
Primaa is a Private company.
-
What is the current valuation of Primaa?
The current valuation of Primaa is .
-
What is Primaa’s current revenue?
The current revenue for Primaa is .
-
How much funding has Primaa raised over time?
Primaa has raised $18M.
-
Who are Primaa’s investors?
Elaia Partners, Super Capital, SWEN Capital Partners, Cenitz, and Clery are 5 of 14 investors who have invested in Primaa.
-
Who are Primaa’s competitors?
AI Medical Service, Optellum, and ScreenPoint Medical are competitors of Primaa.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process